RecruitingNCT02241265
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
Sponsor
University of Oklahoma
Enrollment
20 participants
Start Date
Feb 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Plain Language Summary
Simplified for easier understanding
This trial is studying whether a procedure called bronchial thermoplasty — which uses a thin tube to deliver controlled heat inside the airways — can improve breathing test results in people with severe asthma that is difficult to control with medications alone.
**You may be eligible if...**
- You are 18 years of age or older
- You have been diagnosed with severe asthma that is not well-controlled
- Your breathing test (called spirometry) shows reduced airflow, meaning your lungs have trouble pushing air out quickly — this is measured as a low FEV1 score
- You are considered a good candidate for the bronchial thermoplasty procedure by your doctor
**You may NOT be eligible if...**
- You are under 18 years of age
- You do not have a confirmed diagnosis of severe asthma
- Your doctor has determined you are not a suitable candidate for the procedure
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02241265
Related Trials
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
NCT023278971 location
Role of Genetic Factors in the Development of Lung Disease
NCT000015322 locations
Personalized Environment and Genes Study
NCT003412372 locations
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
NCT06676319229 locations
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
NCT011434801 location